Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Reversible mitochondrial DNA accumulation in nuclei of pluripotent stem cells.

Schneider JS, Cheng X, Zhao Q, Underbayev C, Gonzalez JP, Raveche ES, Fraidenraich D, Ivessa AS.

Stem Cells Dev. 2014 Nov 15;23(22):2712-9. doi: 10.1089/scd.2013.0630. Epub 2014 Aug 4.

2.

Prevalence of monoclonal B-cell lymphocytosis: a systematic review.

Shim YK, Middleton DC, Caporaso NE, Rachel JM, Landgren O, Abbasi F, Raveche ES, Rawstron AC, Orfao A, Marti GE, Vogt RF.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S10-8. doi: 10.1002/cyto.b.20538. Review.

3.

Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.

Salerno E, Scaglione BJ, Coffman FD, Brown BD, Baccarini A, Fernandes H, Marti G, Raveche ES.

Mol Cancer Ther. 2009 Sep;8(9):2684-92. doi: 10.1158/1535-7163.MCT-09-0127. Epub 2009 Sep 1.

4.

Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.

Scaglione BJ, Salerno E, Gala K, Pan M, Langer JA, Mostowski HS, Bauer S, Marti G, Li Y, Tsiagbe VK, Raveche ES.

J Autoimmun. 2009 Feb;32(1):14-23. doi: 10.1016/j.jaut.2008.10.001. Epub 2008 Nov 20.

PMID:
19022624
5.

Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.

Pan M, Kalie E, Scaglione BJ, Raveche ES, Schreiber G, Langer JA.

Biochemistry. 2008 Nov 18;47(46):12018-27. doi: 10.1021/bi801588g. Epub 2008 Oct 21.

PMID:
18937499
6.

Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.

Scaglione BJ, Salerno E, Balan M, Coffman F, Landgraf P, Abbasi F, Kotenko S, Marti GE, Raveche ES.

Br J Haematol. 2007 Dec;139(5):645-57. Epub 2007 Oct 17. Review.

7.

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC, Fredrickson T, Landgraf P, Ramachandra S, Huppi K, Toro JR, Zenger VE, Metcalf RA, Marti GE.

Blood. 2007 Jun 15;109(12):5079-86. Epub 2007 Mar 9.

8.

Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis.

Raveche ES, Schutzer SE, Fernandes H, Bateman H, McCarthy BA, Nickell SP, Cunningham MW.

J Clin Microbiol. 2005 Feb;43(2):850-6.

9.

The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells.

Chong SY, Zhang M, Lin YC, Coffman F, Garcia Z, Ponzio N, Raveche ES.

Cancer Immunol Immunother. 2001 Mar;50(1):41-50.

PMID:
11315509
10.

The role of B-cell-specific activator protein in the response of malignant B-1 cells to LPS.

Zhang M, Chong SY, Raveche ES.

Exp Cell Res. 2001 Apr 1;264(2):233-43.

PMID:
11262180
11.

A poly(C) repeat polymorphism in the promoter of the IL-10 gene in NZB mice.

Morse HR, Bidwell JL, Raveche ES.

Eur J Immunogenet. 1999 Oct;26(5):377-8. No abstract available.

PMID:
10553506
12.

In vivo and in vitro antiproliferative effects of antisense interleukin 10 oligonucleotides.

Parker GA, Peng B, He M, Gould-Fogerite S, Chou CC, Raveché ES.

Methods Enzymol. 2000;314:411-29. No abstract available.

PMID:
10565029
13.

The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).

Peng B, Zhang M, Sun R, Lin YC, Chong SY, Lai H, Stein D, Raveche ES.

Leuk Res. 1998 Jun;22(6):509-16.

PMID:
9678717
14.
15.

Altered CD45 expression in malignant B-1 cells.

Dang AM, Phillips JA, Lin T, Raveche ES.

Cell Immunol. 1996 May 1;169(2):196-207.

PMID:
8620547
16.

A cultured malignant B-1 line serves as a model for Richter's syndrome.

Peng B, Sherr DH, Mahboudi F, Hardin J, Wu YH, Sharer L, Raveché ES.

J Immunol. 1994 Aug 15;153(4):1869-80.

PMID:
8046247
17.

Analysis of immunoglobulin from hybridomas obtained by fusing spontaneously arising CD5+ B-cell clones.

Mahboudi F, Raveché ES.

Ann N Y Acad Sci. 1992 May 4;651:369-72. No abstract available.

PMID:
1376055
18.

The NZB mouse as a model for chronic lymphocytic leukemia.

Phillips JA, Mehta K, Fernandez C, Raveché ES.

Cancer Res. 1992 Jan 15;52(2):437-43.

19.

Regulatory aspects of clonally expanded B-1 (CD5+ B) cells.

Raveché ES, Phillips J, Mahboudi F, Dang A, Fernandes H, Ramachandra S, Lin T, Peng B.

Int J Clin Lab Res. 1992;22(4):220-34.

PMID:
1467538
20.

Hyperdiploid-CD5-positive B cells in mouse.

Raveche ES, Tjio JH.

Int J Hematol. 1991 Feb;54(1):25-35.

PMID:
1954348
21.

Influence of host environment on growth of clonal CD5+B (Lyl+B) cells.

Raveche ES, Lin TZ, Conroy J, Tjio JH, Steinberg AD, Rudolfsky UA, Phillips JA.

Autoimmunity. 1991;10(3):217-25.

PMID:
1721848
22.

Effects of induced anemia in normal and autoimmune mice.

Raveche ES, Smith H, Noguchi P, Chused TM, Steinberg AD.

Immunol Invest. 1990 Aug;19(4):307-18.

PMID:
2210804
23.

Possible immunoregulatory role for CD5 + B cells.

Raveche ES.

Clin Immunol Immunopathol. 1990 Aug;56(2):135-50. Review.

PMID:
1696187
24.

In vivo effects of hyperdiploid Ly-1+ B cells of NZB origin.

Raveche ES, Lalor P, Stall A, Conroy J.

J Immunol. 1988 Dec 15;141(12):4133-9.

PMID:
3264305
25.

Dietary copper deficiency and autoimmunity in the NZB mouse.

Mulhern SA, Raveche ES, Smith HR, Lal RB.

Am J Clin Nutr. 1987 Dec;46(6):1035-9.

PMID:
3318378
26.

Clonal expansion of abnormal B cells in old NZB mice.

Seldin MF, Conroy J, Steinberg AD, D'Hoosteleare LA, Raveche ES.

J Exp Med. 1987 Nov 1;166(5):1585-90.

27.

Effect of anti-Ia treatment on the production of anti-DNA antibody by NZB mice.

Klinman DM, Lefkowitz MD, Raveche ES, Steinberg AD.

Eur J Immunol. 1986 Aug;16(8):939-44.

PMID:
3488912
28.

Oncogene expression in autoimmune and normal peripheral blood mononuclear cells.

Klinman DM, Mushinski JF, Honda M, Ishigatsubo Y, Mountz JD, Raveche ES, Steinberg AD.

J Exp Med. 1986 May 1;163(5):1292-307.

29.

Differential proliferative responses of B cells from BALB/c and autoimmune NZB mice to B-cell growth factor(s).

Gutierrez C, Howard M, Gaspar ML, Raveche ES.

Clin Immunol Immunopathol. 1986 May;39(2):319-28.

PMID:
3486069
30.

Role of T cells in sex differences in syngeneic bone marrow transfers.

Raveche ES, Santoro T, Brecher G, Tjio JH.

Exp Hematol. 1985 Nov;13(10):975-80.

PMID:
3902497
31.
32.

Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.

DeFranco AL, Raveche ES, Paul WE.

J Immunol. 1985 Jul;135(1):87-94.

PMID:
3873499
33.

Analysis of B-cell subpopulations. I. Relationships among splenic xid, Ly 1+, and Lyb 5+ B cells.

Smith HR, Yaffe LJ, Chused TM, Raveche ES, Klinman DM, Steinberg AD.

Cell Immunol. 1985 Apr 15;92(1):190-6.

PMID:
3878230
34.

Comparison of response to stem cell differentiation signals between normal and autoimmune mouse strains.

Raveche ES, Chused TM, Steinberg AD, Laskin CA, Edison LJ, Tjio JH.

J Immunol. 1985 Feb;134(2):865-71.

PMID:
3880791
35.

Genetic studies in NZB mice. VI. Association of autoimmune traits in recombinant inbred lines.

Miller ML, Raveche ES, Laskin CA, Klinman DM, Steinberg AD.

J Immunol. 1984 Sep;133(3):1325-31.

PMID:
6086755
36.

NIH conference. Systemic lupus erythematosus: insights from animal models.

Steinberg AD, Raveché ES, Laskin CA, Smith HR, Santoro T, Miller ML, Plotz PH.

Ann Intern Med. 1984 May;100(5):714-27. Review.

PMID:
6370068
37.

Studies of immune defective RIII/AnN mice.

Mountz JD, Raveche ES, Noguchi PD, Steinberg AD.

Clin Immunol Immunopathol. 1984 Mar;30(3):346-61.

PMID:
6607800
38.

Analysis of thymocyte subpopulations following treatment with sex hormones.

Novotny EA, Raveche ES, Sharrow S, Ottinger M, Steinberg AD.

Clin Immunol Immunopathol. 1983 Aug;28(2):205-17.

PMID:
6603317
39.

Comparison of stem-cell recovery in autoimmune and normal strains.

Raveche ES, Laskin CA, Rubin C, Tjio JH, Steinberg AD.

Cell Immunol. 1983 Jul 1;79(1):56-67.

PMID:
6861213
40.

The magnitude of the autologous mixed lymphocyte reaction itself is regulated.

Steinberg AD, Luger TA, Raveche ES, Siminovitch K, Smolen JS.

Behring Inst Mitt. 1983 May;(72):153-62. No abstract available.

PMID:
6242333
41.

Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function.

Smith HR, Green DR, Smathers PA, Gershon RK, Raveche ES, Steinberg AD.

Clin Exp Immunol. 1983 Mar;51(3):579-86.

42.

The human autologous mixed lymphocyte reaction. II. Analysis of activation and proliferation.

Smolen JS, Raveche ES, Steinberg RT, Sharrow SO, Fauci AS, Steinberg AD.

J Clin Lab Immunol. 1982 Dec;9(3):185-92.

PMID:
6220155
43.

Studies of the induction of anti-DNA in normal mice.

Smith HR, Green DR, Raveche ES, Smathers PA, Gershon RK, Steinberg AD.

J Immunol. 1982 Dec;129(6):2332-4.

PMID:
6183332
44.

Cell cycle analysis of lymphocyte activation in normal and autoimmune strains of mice.

Raveche ES, Steinberg AD, DeFranco AL, Tjio JH.

J Immunol. 1982 Sep;129(3):1219-26.

PMID:
6125541
45.

Genetic, environmental, and cellular factors in the pathogenesis of systemic lupus erythematosus.

Steinberg AD, Raveche ES, Laskin CA, Miller ML, Steinberg RT.

Arthritis Rheum. 1982 Jul;25(7):734-43. No abstract available.

PMID:
6179521
46.

Frequency of B lymphocytes responsive to anti-immunoglobulin.

Defranco AL, Raveche ES, Asofsky R, Paul WE.

J Exp Med. 1982 May 1;155(5):1523-36.

47.

Flow cytometric analysis of in vivo activation of murine spleen cells.

Raveché ES, Steinberg AD.

J Immunopharmacol. 1982-1983;4(3):163-81.

PMID:
6764220
48.

Genetic studies in NZB mice. V. Recombinant inbred lines demonstrate that separate genes control autoimmune phenotype.

Raveche ES, Novotny EA, Hansen CT, Tjio JH, Steinberg AD.

J Exp Med. 1981 May 1;153(5):1187-97.

49.

T cell abnormalities in NZB mice occur independently of autoantibody production.

Taurog JD, Raveche ES, Smathers PA, Glimcher LH, Huston DP, Hansen CT, Steinberg AD.

J Exp Med. 1981 Feb 1;153(2):221-34.

50.

Analysis of NZB hyperdiploid spleen cells.

Raveche ES, Alabaster O, Tjio JH, Taurog J, Steinberg AD.

J Immunol. 1981 Jan;126(1):154-60.

PMID:
7451964

Supplemental Content

Loading ...
Support Center